Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SpareBank 1 SR-Bank ASA: Increasing home mortgage rates

In light of Norges Bank raising its policy rate and higher borrowing costs for SpareBank 1 SR-Bank, the bank is adjusting its mortgage rates for existing customers by up to 0.25 percentage points. “Money market rates have risen over the winter, and faster than Norges Bank’s policy rate. We are adjusting our mortgage rates because the cost of borrowing has increased,” says Roger Lund Antonesen, Executive Vice President Retail Market of SpareBank 1 SR-Bank. While there is some uncertainty internationally, Norway is experiencing high levels of economic activity and low unemployment. Due

LMK Group Board proposes dividend and nominating committee proposes Johan Kleberg to the Board

The Board of Directors of LMK Group AB (publ) has decided to propose the distribution of a dividend of 1.75 SEK per share for 2022, corresponding to a total amount of 22.2 MSEK. Further, the nominating committee has proposed Johan Kleberg as new member of the Board. The Annual General Meeting will be held on April 27, 2022.The Board has proposed an updated dividend policy which is meant to provide shareholders with a dividend that offers a good direct return while giving the company the opportunity to invest in strategic growth opportunities. The target dividend over the next 3 to 5 years

NOTICE TO ATTEND LMK GROUP AB (PUBL)'S ANNUAL GENERAL MEETING

The shareholders of LMK Group AB (publ), reg. no. 559021-1263 ("LMK Group" or the "Company"), are hereby given notice to attend the annual general meeting to be held on Wednesday, 27 April 2022 at 15.00 pm at Scandic Grand Central's premises at Kungsgatan 70, 111 20 Stockholm, Sweden. The convention hall opens for registration to the annual general meeting at 14.15 pm.Participation Shareholders are entitled to participate in the annual general meeting if they: are entered in the share register maintained by Euroclear Sweden AB on Tuesday, 19 April 2022; and have notified the

Akelius buys back EUR 350 million hybrid bonds

Akelius buys back EUR 350 million hybrid bonds through a public offer. Allocation between Akelius’ two hybrid bonds- EUR 185 million nominal at purchase price of EUR 1,030.23 per EUR 1,000 nominal amount of the bond maturing 2078, first call July 2023, ISIN XS1788973573 - EUR 165 million nominal at purchase price of EUR 933.75 per EUR 1,000 nominal amount of the bond maturing 2081, first call February 2026, ISIN XS2110077299 BNP Paribas and Danske Bank were the dealer managers.Stockholm, 2022-03-28 Leiv SynnesCFO, Vice President+46 70 558 55 23leiv.synnes@akelius.se

SaltX Annual Report for 2021 has been published

Today, SaltX Technology Holding AB (publ) publishes its Annual Report (in Swedish) describing the 2021operations. It can be downloaded at https://saltxtechnology.com/investor/ For further information, please contact:Carl-Johan Linér (CEO) +46 705-32 08 08Harald Bauer (CFO) +46 708-10 80 34 About SaltX Technology SaltX Technology develops and sells a patented energy storage solution. SaltX´s mission is to develop and offer sustainable technology and solutions that clearly benefit customers, the climate, and society. SaltX Technology's shares are listed on the Nasdaq First North

Hansa Biopharma and Medison Pharma announce marketing authorization in Israel for Idefirix[®] (imlifidase) for desensitization treatment of highly sensitized kidney transplant patients

· Israel is the first market outside of Europe to grant regulatory approval for Idefirix[®] · The decision by Israel’s regulatory authority provides highly sensitized patients in Israel with the opportunity to receive Idefirix[®] as desensitization treatment · The approval to use Idefirix[®] as defined in indication approved by the European Medicines Agency (EMA)[1,2] Lund, Sweden and Petach Tikva, Israel March 28, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, and its partner Medison Pharma (“Medison”)

Redwood Pharma receives approval from the Austrian drug authority to start RP501 clinical trial

Redwood Pharma has received approval from the Austrian Federal Office for Safety in Health Care (BASG) to initiate the clinical trial of RP501, the company’s new drug candidate for first-line treatment of dry eye disease. Following the approval from the Austrian Ethics Commission earlier this month, this is the second and final approval required for the company to begin clinical work.To support future product claims, Redwood Pharma is conducting a single-center trial led by Prof. Gerhard Garhöfer who states, “We are excited to start this trial at the Medical University of Vienna, Austria.

New £5.8m Centre for Health Innovation in Stafford opens up world of opportunity for students, business and industry

Staffordshire University has opened the doors of its new £5.8 million state-of-the-art Centre for Health Innovation.Featuring the most advanced health simulation technology, the Centre offers a series of flexible and immersive simulation spaces designed to enhance clinical competency and the learning experience for students. The new Centre has been part-funded by Stoke-on-Trent & Staffordshire Local Enterprise Partnership (LEP) via the Government’s Getting Building Fund. The LEP allocated £2.89m to this scheme to help bring forward the pioneering facility and generate further opportunity

Cyclyx and its members introduce 10 to 90®, a consumer engagement brand designed to divert more plastics from landfill

PORTSMOUTH, New Hampshire, USA, March 28, 2022 – Cyclyx International , a consortium-based waste plastic innovation company, together with its members, is introducing its mission brand, 10 to 90®, and associated 10 to 90 Challenge. The 10 to 90 Challenge is a series of new takeback and engagement programs designed to divert more low-quality waste plastics away from landfill and into the Cyclyx system, where those waste plastics can be recycled with the ultimate goal to increase recycling rates of plastics from 10% to 90%.  Cyclyx, in collaboration with its members,

Buybacks of shares in Alfa Laval during week 12, 2022

During the period March 21 – March 25, 2022, Alfa Laval AB (publ) (LEI code: 549300UCKT2UK88AG251) has repurchased in total 120,150 own shares (ISIN: SE0000695876) as part of the share buyback program initiated by the Board of Directors in order to secure optimized capital structure.The share buybacks form part of the SEK 2 billion share buyback program, which Alfa Laval announced on April 27, 2021. The share buy-back program, which runs between April 28, 2021 and April 25, 2022, is being carried out in accordance with the EU Market Abuse Regulation (MAR) and the Commission Delegated

SOTKAMO SILVER HAS SIGNED A NEW SENIOR LOAN AGREEMENT WITH SUSTAINABILITY TARGETS AND PUBLISHES THE RESULTS OF THE WRITTEN PROCEDURE OF EUR 13,200,000 SENIOR FIXED RATE NOTES

Press release March 28, 2022Stockholm 15:00 CET    Press release: Stockholm, March 28, 2022, 15.00 CET Sotkamo Silver AB’s wholly owned subsidiary Sotkamo Silver Oy (the “Company”) has entered into a EUR 14,600,000 senior loan agreement (the “New Senior Loan”) as a part of the refinancing of the Company's instruments that was announced on 11 January 2022. Summary of the new senior loan agreement: · The New Senior Loan carries an annual interest of EURIBOR 12 months (min. 0 %) and a margin of 6.5 % · The term of the New Senior Loan is 4 years and the termination date

Mattias Bodin new Environmental and Sustainability Director at OrganoClick AB

Mattias Bodin has been appointed new Environmental and Sustainability Director at OrganoClick and part of Group management. Mattias has previously worked for almost 20 years within the HM Group, in positions such as Chemical responsible, Group manager HM Global product comliance department, Sustainability expert for Materials and Innovation most recently as HM Circular Innovation Lab Lead."We are very pleased that Mattias joins OrganoClick and our continued journey. His long experience from chemicals, materials and sustainability issues from the HM Group will be very valuable for us and our

Decisions by Fortum Corporation's Annual General Meeting 2022

FORTUM CORPORATION STOCK EXCHANGE RELEASE 28 MARCH 2022 AT 15:55 EEST The Annual General Meeting of Fortum Corporation was held at the company headquarters in Espoo, Finland on 28 March 2022 under special arrangements. The Annual General Meeting adopted the Financial Statements and the Consolidated Financial Statements for the financial period 1 January-31 December 2021. In accordance with the proposal of the Board of Directors, the Annual General Meeting resolved that a dividend of EUR 1.14 per share will be paid for the financial year that ended on 31 December 2021, which

Tokmanni brings low prices to the Lippulaiva urban centre in the Greater Espoonlahti area in Espoo – The newest store will be Tokmanni’s 20th store in the Helsinki metropolitan area

Tokmanni     Press release     28 March 2022 at 3:45 p.m. Tokmanni, Finland’s largest variety discount retailer, will open its newest store at the new Lippulaiva urban centre  in the Greater Espoonlahti area on Thursday 31 March 2022 at 10 am. Located near the Western Highway (Länsiväylä), the new store will be the fifth Tokmanni store in Espoo, the 20th in the Helsinki metropolitan area and the 197th in Finland. Located on the second floor of the Lippulaiva urban centre, the store will offer a selection designed especially for urban residents, including

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN IRISITY AB (PUBL)

The shareholders in Irisity AB (publ), reg. no. 556705-4571 (the “Company” or “Irisity”), with its registered office in Gothenburg, are hereby invited to the annual general meeting on Wednesday 27 April 2022 at Radisson Blu Lindholmen, Lindholmspiren 4, SE-417 56 Gothenburg.NOTIFICATION, ETC. Notification Shareholders who wish to participate at the annual general meeting shall: · firstly, be entered in the share register maintained by Euroclear Sweden AB no later than on Tuesday 19 April 2022 (for nominee-registered shares, also see “Nominee-registered shares” below), ·

Decisions of the Annual General Meeting and Board of Directors of Caverion Corporation

Caverion Corporation Stock exchange release 28 March 2022 at 3.45 p.m. EESTDecisions of the Annual General Meeting and Board of Directors of Caverion CorporationCaverion Corporation’s Annual General Meeting was held today on 28 March 2022 in Helsinki under the so-called Temporary Act (375/2021) without the shareholders’ or their proxy representatives’ presence at the meeting venue. The Annual General Meeting adopted the Financial Statements and the consolidated Financial Statements for the year 2021 and discharged the members of the Board of Directors and the President and CEOs from

Company Announcement No. 40, 2022 - Fixing of coupons with effect as from 1 April 2022

The coupons for the Capped floaters listed below will be changed taking effect 1 April 2022. The new coupons will be in force from 1 April 2022 – 30 September 2022.   Capped floater with a 5 per cent interest rate cap, CF   DK0002015106, maturity 2038, new coupon as per 1 April 2022:   0.76% p.a.   Capped floater with a 5 per cent interest rate cap, CF OA DK0002015296, maturity 2038, new coupon as per 1 April 2022:   0.76% p.a.   Capped floater with a 6 per cent interest rate cap, CF DK0002021427, maturity 2041, new coupon as per 1 April 2022:   0.41% p.a.

DanCann Pharma A/S appoints Sarah Mai Lykke-Kjeldsen as new COO

COPENHAGEN, Denmark, 28 March 2022 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), hereby announce that the Company has appointed Sarah Mai Lykke-Kjeldsen as new Chief Operating Officer (“COO”).DanCann Pharma A/S was formed in 2018 and has since then undergone an extensive development and maturation process. Following the establishment of the Biotech Pharm1 production facilities and last year's acquisition of the wholesale company CannGros ApS, the ambitious pharma company now focuses on strengthening the organization in order to ensure stable future operations.

New article published on the QuickMIC® system

Uppsala, 28 March, 2022. Gradientech AB (publ) today announces a new scientific publication of its diagnostic QuickMIC® system, demonstrating significant reduction in turnaround time for antibiotic guidance of critically ill sepsis patients.The scientific publication is a collaboration between Gradientech and researchers and clinicians at Uppsala University and Uppsala University Hospital, Sweden, with the primary aim to evaluate the performance of the QuickMIC system regarding speed, accuracy and precision in comparison to traditional antibiotic susceptibility testing (AST) methods. The

Correction MAR label – SelectImmune Pharma’s CEO recruited to new position

The correction refers to the MAR label. This press release should be without the MAR label. Selectimmune Pharma’s CEO Ann Gidner will leave SelectImmune Pharma, having accepted an offer from a non-competing Life-Science company. Ann Gidner will remain in the CEO role during the notice period of one month. The board has initiated the recruitment of a new CEO for the company.”We are grateful for the contributions of Ms Gidner and wish her all the best in her next position,” says Catharina Svanborg, Chairman of the board, SelectImmune Pharma. For more information, please contact:

DanCann Pharma A/S: CFO Mads Møller Kristensen and DanCann Pharma will be parting ways as of 31 May 2022

COPENHAGEN, Denmark, 28 March 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the CFO Mads Møller Kristensen and the Company will be parting ways.DanCann Pharma and CFO Mads Møller Kristensen have decided to stop the collaboration at the end of May 2022. CEO, Jeppe Krog Rasmussen, comments: “Since the appointment as CFO in April 2020, Mads has developed a well-functioning finance function from scratch, and at the same time he has been a big contributor to the development of the Company. Mads has

SEB publishes restated comparative figures for 2020-2021

SEB publishes restated comparative figures for the years 2020-2021 to reflect organisational changes, including the formation of SEB’s new division Private Wealth Management & Family Office, as well as presentation changes The restatement does not affect SEB’s net profit or equity for these years. The main reorganisations reflected in the restated comparative figures are: · Private Wealth Management & Family Office, previously included in the division Corporate & Private Customers, is now reported as a separate division and reporting segment. · The Life division’s sales unit is

Betsson launches sportsbook in Colorado, U.S.A.

Earlier today, Betsson launched its mobile app sportsbook product under the Betsafe brand in the state of Colorado, in partnership with Dostal Alley Casino . The Business-to-Consumer (B2C) launch of Betsafe serves as an opportunity to showcase Betsson’s proprietary, U.S.-adapted sportsbook for new and existing operators on the market, making it an important component of the company’s Business-to-Business (B2B) strategy in the country.In connection with the launch, Betsson has also opened an

Bulletin from the extraordinary general meeting on March 28, 2022, in SynAct Pharma AB

Today, on March 28, 2022, an extraordinary general meeting was held in SynAct Pharma AB. The meeting was held only by advance voting (postal vote) in accordance with temporary legislation. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes.Election of new board member and remuneration for the new board member The meeting resolved, in accordance with the proposal from the Nomination Committee, to elect Kerstin Hasselgren as new ordinary board member for the time period up until the end of the next annual general meeting

There are no items matching the current filter
There are no more items matching the current filter
Back to top